Telcon RF Pharmaceutical Inc. logo

Telcon RF Pharmaceutical Inc. (200230)

Market Closed
11 Aug, 06:30
KRX SM KRX SM
2,395. 00
+50
+2.1322%
47.78B Market Cap
- P/E Ratio
- Div Yield
38,199 Volume
- Eps
2,345
Previous Close
Add Transaction
Day Range
2,300 2,450
Year Range
1,700 44,050
Want to track 200230 and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!

Telcon RF Pharmaceutical Inc. (200230) Statistics

Valuation metrics

Market Cap 47.78B
Enterprise value 47.84B
Trailing P/E (ttm) -0.72
Forward P/E -
PEG ratio -0.01
Price/Sales (ttm) 0.37
Price/Book (mrq) 0.16
Enterprise Value/Revenue 1.12
Enterprise Value/EBITDA 3.47

Overview

Shares outstanding -
Float -
Shares short -
% Held by insiders -
% Held by institutions -
Average volume (10 days) 90.5K
Average volume (90 days) 209.46K

Price summary

52-Week low 1,700
52-Week high 44,050
Beta -
50-Day moving average 2,439.69
200-Day moving average 1,462.54

Dividends and splits

Forward annual dividend rate -
Forward annual dividend yield -
Trailing annual dividend rate -
Trailing annual dividend yield -
5-Year annual dividend yield -
Payout ratio -
Dividend Date -
Ex-Dividend Date -
Last split factor 3:1
Last split Date 22 Aug 2025

Financials

Fiscal year

Fiscal year ends -
Most recent quarter (mrq) -

Profitability

Profit margin -0.19%
Operating margin 0.02%

Operational effectiveness

Return on assets -0.06%
Return on equity -0.09%

Income Statement

Revenue (ttm) -
Revenue per share (ttm) 6,258.22
Quarterly revenue growth (yoy) -
Gross profit (ttm) -
EBITDA -
Net income to common (ttm) -
Diluted EPS (ttm) -1,211.17
Quarterly earnings growth (yoy) -

Balance Sheet

Total cash (mrq) -
Total cash per share (mrq) 4,954.06
Total debt (mrq) -
Total Debt/Equity (mrq) 0.41
Current ratio (mrq) 1.24%
Book value per share (mrq) 14,219.46

Cash Flow

Cash flow statement -
Levered free cash flow (LFCF) -